Adequate selenium status in patients with COVID-19

The article published in Nutrition – an Elsevier journal - with an impact factor of 3.4 - shows the importance of selenium in fighting against SARS-CoV-2 viral infection. Sabinsa brand name used is SeleniumSELECT®, the L-Selenomethionine, developed and patented by Sabinsa.

The major highlights of the study are :

• Nutrition and immune status are two critical aspects of fighting the virus successfully.
• Selenium is an important trace element required for optimum immune response, antioxidant activity and antiviral response
• Selenium deficiency is reported to affect 500 million to 1 billion people worldwide, mainly due to inadequate intake from diet
• COVID-19 Patients had significantly lower selenium level in serum compared to healthy noninfected individuals
• Selenium deficiency may be a predisposing factor for SARS-CoV-2 infection
• Selenium supplementation may be helpful to reduce the susceptibility to infection.

Read the study : https://doi.org/10.1016/j.nut.2020.111053